Physician profile
Basar Atalay
NPI 1710639364
$3,400.30
in general payments reported to CMS, 2019-2025
7 companies · $3,138 in 2025
The $3,138 reported for 2025 was more than what 75% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $263 · 2025: $3,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,889 · Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,889.35 |
| Food and Beverage | $1,510.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,439.45 | 2024-2025 | O-Arm, Infinity Occipitocervical Upper Thoracic System, Catalyft Pl Expandable Interbody System |
| Medical Device Business Services, INC. | $746.40 | 2025 | Teligen |
| Elite Orthopedics, LLC | $565.10 | 2025 | |
| Si-Bone, INC. | $283.08 | 2025 | |
| Depuy Synthes Sales INC. | $226.98 | 2025 | Teligen, Velys, Symphony |
| Cerapedics INC. | $117.79 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Polaris Technology Solutions LLC | $21.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basar Atalay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.